Objective: To explore the clinical application of three-dimensional face virtual plastic system. Methods: 80 patients (28 males and 52 females, aged 18-40 years) who underwent facial plastic surgery in Xiangya Hospital were sampled with two-dimensional human color images and three-dimensional human point cloud data continuously. Face detection was performed on the collected data, and super-resolution fusion was performed on the detected three-dimensional human point clouds. A three-dimensional face model was built using the fused three-dimensional face point cloud data, and the texture mapping technology was used to realize the mapping from two-dimensional color image to three-dimensional face model. Finally, patients and doctors perform virtual surgery on the three-dimensional face model interactively to obtain satisfactory target three-dimensional face model. By comparing the changes of three-dimensional face model before and after virtual surgery, the data to be adjusted in the facial plastic surgery were obtained, and 80 patients received facial plastic surgery according to the data. The three-dimensional face model of patients was reconstructed one year after operation, and then compared with the model of virtual surgery to evaluate the effect of plastic surgery. Results: 80 patients underwent plastic surgery with the above method, including 6 cases of medial canthus, 9 cases of lateral canthus, 20 cases of rhinoplasty, 25 cases of lip thinning, and 20 cases of facial fat grafting. One year after operation, 80 patients were satisfied with the result of plastic surgery. Conclusions The three-dimensional virtual facial plastic system makes the process of plastic design individualized, quantified and digitized. It enables patients to have a better understanding of prognosis in advance, facilitating the communication between doctors and patients, and reducing unnecessary medical disputes.

Objective:To investigate the prognoses of pulmonary adenocarcinoma patients with leptomeningeal metastases (LM) and explore their influencing factors.Methods:A retrospective analysis was performed. The clinical data, imaging features and treatment plans of pulmonary adenocarcinoma patients with LM admitted to our hospital from January 2010 to June 2021 were collected. Overall survival (OS) was used as the prognostic evaluation criterion and patients were divided into good prognosis group (OS≥6 months) and poor prognosis group (OS<6 months) accordingly. Logistic regression analysis was used to evaluate the influencing factors for prognoses of pulmonary adenocarcinoma patients with LM. These patients were grouped according to different Karnofsky performance status (KPS) scores and different treatment methods, and survival curves were drawn to compare their OS.Results:A total of 173 pulmonary adenocarcinoma patients with LM were enrolled in the study, including 75 with good prognosis and 87 with poor prognosis. There were significant differences in the KPS scores, pulmonary adenocarcinoma lesion controlled status, giving third generation tyrosine kinase inhibitor (TKI) therapy or not, giving systemic chemotherapy and/or whole brain radiotherapy or not between the two groups ( P<0.05). Multivariate Logistic regression analysis showed that KPS scores and pulmonary adenocarcinoma lesion controlled status were independent influencing factors for prognoses ( OR=4.186, 95%CI: 1.583-11.070, P=0.004; OR=4.198, 95%CI: 1.499-11.760, P=0.006). Survival curves showed median OS of 8.2 months for all patients ( 95%CI: 6.5-9.8). The OS in patients with low-risk(KPS scores≥60) was significantly higher than that in patients with high-risk(KPS scores<60), that in patients accepted TKI treatment was significantly higher than that in patients not accepted TKI treatment, and that in patients accepted TKI and systemic chemotherapy was significantly higher than that in patients accepted TKI alone ( P<0.05). Conclusion:Patients with high KPS scores and controlled pulmonary adenocarcinoma can have relatively good prognosis; TKI treatment and combination therapy may prolong OS of these patients.